Ezetimibe

Inkcazelo emfutshane:

Igama le-API Isalathiso Inkcazo USDMF EU DMF CEP
Ezetimibe Hyperlipidemia Endlwini/USP 24511  


Iinkcukacha zeMveliso

Iithegi zeMveliso

IINKCUKACHA ZEMVELISO

Imvelaphi

I-Ezetimibe inamandla kwaye inoveli inhibitor yokufunxa i-cholesterol [1].

I-cholesterol yi-lipid molekyuli kwaye iyafuneka ukuze kwakhiwe kwaye kugcinwe i-membrane ingqibelelo yesakhiwo kunye nolwelo.Kwakhona, isebenza njenge-precursor ye-vitamin D, i-bile acids kunye neehomoni ze-steroid.

Kwiiseli ezihlukeneyo zeCaco-2 ezifakwe kwi-carotenoid (1 μM), ezetimibe (10 mg / L) zithintele ukuthuthwa kwe-carotenoid kunye ne-50% inhibition ye-ɑ-carotene kunye ne-β-carotene.Kwakhona, yayinqanda ukuthuthwa kwe-β-cryptoxanthin, i-lycopene kunye ne-lutein: zeaxanthin (1: 1).Kwangaxeshanye, ezetimibe inqanda ukuthuthwa kwe-cholesterol ngama-31%.I-Ezetimibe iyancipha ukubonakaliswa kwe-surface receptors SR-BI, i-ATP ebopha i-cassette transporter, i-subfamily A (ABCA1), i-Niemann-Pick uhlobo lwe-C1 Njenge-protein ye-1 (NPC1L1) kunye ne-retinoid acid receptor (RAR) γ, i-sterol-regulatory element ebopha iiprotheni SREBP -1 kunye ne-SREBP-2, kunye ne-X receptor yesibindi (LXR)β [3].

Kwi-apolipoprotein E knockout (apoE-/-) iigundane, ezetimibe (3 mg/kg) inqanda ukufunxwa kwe-cholesterol ngama-90%.I-Ezetimibe inciphisa i-cholesterol ye-plasma, yandisa amanqanaba e-HDL, kwaye inqanda ukuqhubeka kwe-atherosclerosis [1].Kwinqanaba lesi-III izilingo zabantu, i-Ezetimibe (10 mg) yanciphisa kakhulu amanqanaba e-cholesterol ye-LDL, i-cholesterol epheleleyo kunye ne-triglycerides kwaye yandisa izinga le-cholesterol ye-HDL [2].

IiReferensi:
[1].UDavis HR Jr, Compton DS, Hoos L, et al.I-Ezetimibe, i-cholesterol absorption inhibitor enamandla, inqanda ukukhula kwe-atherosclerosis kwiimpuku ze-ApoE knockout.I-Arterioscler Thromb Vasc Biol, i-2001, i-21 (12): 2032-2038.
[2].Clader JW.Ukufunyanwa kwe-ezetimibe: umbono ovela ngaphandle kwe-receptor.J Med Chem, 2004, 47(1): 1-9.
[3].Ngexesha A, Dawson HD, Harrison EH.Ukuthuthwa kwe-Carotenoid kuyancipha kwaye ibonakaliso ye-lipid transporters SR-BI, NPC1L1, kunye ne-ABCA1 iyancipha kwiiseli zeCaco-2 eziphathwa nge-ezetimibe.J Nutr, 2005, 135 (10): 2305-2312.

Inkcazo

I-Ezetimibe (i-SCH 58235) yi-cholesterol enamandla yokufunxa inhibitor.I-Ezetimibe yi-Niemann-Pick C1-like1 (NPC1L1) inhibitor, kwaye i-activator ye-Nrf2 enamandla.

I-In vitro

I-Ezetimibe (Eze) isebenza njenge-activator ye-Nrf2 enamandla ngaphandle kokubangela i-cytotoxicity.I-Ezetimibe iphucula ukusebenza kwe-Nrf2, njengoko ityhilwe luciferase intatheli yovavanyo.I-Ezetimibe iphinda ilawule i-Nrf2 ye-target genes, kuquka i-GSTA1, i-heme oxygenase-1 (HO-1) kunye ne-Nqo-1 kwi-Hepa1c1c7 kunye neeseli ze-MEF.I-Ezetimibe ilawula ijene ekujoliswe kuyo ye-Nrf2 kwiiseli ze-Nrf2+/+ ze-MEF, kanti oku kufakwa kuvalwe ngokupheleleyo kwiiseli ze-Nrf2-/- MEF.Idityaniswe kunye, i-Ezetimibe isebenza njengenoveli i-Nrf2 inducer ngendlela ezimeleyo ye-ROS[1].I-hepatocytes yabantu i-huh7 yabantu yenziwe kwangaphambili nge-Ezetimibe (10μM, 1 h) kunye ne-incubated nge-palmitic acid (PA, 0.5 mM, 24 h) ukubangela i-hepatic steatosis.Unyango lwe-Ezetimibe lunciphisa kakhulu amanqanaba e-PA-yonyuso ye-triglycerides (TG), ehambelana nesifundo sethu sezilwanyana.Unyango lwe-PA lubangele ukuhla malunga ne-20% kwi-mRNA ibonakaliso ye-ATG5, ATG6, kunye ne-ATG7, eyonyuswe ngonyango lwe-Ezetimibe.Ukongeza, unyango lwe-Ezetimibe lwandise kakhulu ukucutha okubangelwa yi-PA kwi-LC3 yobuninzi beprotheyini [2].

I-MCE ayizange iqinisekise ngokuzimeleyo ukuchaneka kwezi ndlela.Zenzelwe ireferensi kuphela.

Ulawulo lwe-Ezetimibe (Eze) lunciphisa ubunzima besibindi beempuku ezondla i-methionine- kunye ne-choline-deficient (MCD) yokutya.Oku kuhambelana neziphumo eziluncedo ze-Ezetimibe kwi-hepatic steatosis.I-histology yesibindi ibonisa amathontsi atyebileyo e-macrovesicular amaninzi kwiimpuku kukutya kwe-MCD, kodwa unyango lwe-Ezetimibe lulehlisa ngokuphawulekayo inani kunye nobukhulu baloo mathontsi.Ngaphaya koko, i-hepatic fibrosis kwiimpuku ezondla ukutya kwe-MCD ithotywa kakhulu ngu-Ezetimibe[1].Amanqanaba egazi kunye nesibindi se-lipid kuquka i-TG, i-fatty acids yamahhala (FFA), kunye ne-cholesterol epheleleyo (TC) iyancipha kakhulu kwiigundane ze-OLETF eziphathwa nge-Ezetimibe.Ngaphezu koko, iigundane ze-OLETF zibonisa amanqanaba aphezulu e-serum ye-glucose, i-insulin, i-HOMA-IR, i-TG, i-FFA, kunye ne-TC kunezilwanyana ze-LETF, ezincitshiswe kakhulu yi-Ezetimibe.Ukongeza, uhlalutyo lwe-histological lubonise ukuba iigundane zokulawula i-OLETF zibonise amathontsi e-lipid amakhulu kwi-hepatocytes kunolawulo lwe-LETO oluhambelana neminyaka, oluthotywa kulawulo lwe-Ezetimibe[2].

Ugcino

Umgubo

-20°C

Iminyaka emi-3
 

4°C

iminyaka eyi-2
Kwi-solvent

-80°C

Iinyanga ezi-6
 

-20°C

Inyanga eyi-1

Ubume beMichiza

Ezetimibe

ISIQINISEKISO

2018 GMP-2
原料药GMP证书201811(captopril ,thalidomide etc)
GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co
FDA-EIR-Letter-201901

ULAWULO LOMgangatho

Quality management1

Isindululo18Iiprojekthi zoVavanyo loBulunga ezivunyiweyo4, kwaye6iiprojekthi ziphantsi kolwamkelo.

Quality management2

Inkqubo yolawulo lomgangatho wehlabathi ephucukileyo ibeke isiseko esiluqilima sokuthengisa.

Quality management3

Ukongamela umgangatho kutyhutyha umjikelo wobomi bemveliso ukuqinisekisa umgangatho kunye nesiphumo sonyango.

Quality management4

Iqela leMicimbi yoLawulo lobuGcisa lixhasa iimfuno zomgangatho ngexesha lesicelo nokubhaliswa.

ULAWULO LWEMVELISO

cpf5
cpf6

Korea Countec Bottled Packaging Line

cpf7
cpf8

Taiwan CVC Bottled UkuPakisha Line

cpf9
cpf10

Italy CAM Board Packaging Line

cpf11

Umatshini wokuQinisa iFette waseJamani

cpf12

Japan Viswill Tablet Detector

cpf14-1

I-DCS Control Room

UMQHUBA

Intsebenziswano yamazwe ngamazwe
International cooperation
Intsebenziswano yasekhaya
Domestic cooperation

  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi